Stock Analysis on Net

Teradyne Inc. (NASDAQ:TER)

This company has been moved to the archive! The financial data has not been updated since May 3, 2024.

Cash Flow Statement 
Quarterly Data

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Teradyne Inc., consolidated cash flow statement (quarterly data)

US$ in thousands

Microsoft Excel
3 months ended: Mar 31, 2024 Dec 31, 2023 Oct 1, 2023 Jul 2, 2023 Apr 2, 2023 Dec 31, 2022 Oct 2, 2022 Jul 3, 2022 Apr 3, 2022 Dec 31, 2021 Oct 3, 2021 Jul 4, 2021 Apr 4, 2021 Dec 31, 2020 Sep 27, 2020 Jun 28, 2020 Mar 29, 2020 Dec 31, 2019 Sep 29, 2019 Jun 30, 2019 Mar 31, 2019
Net income 64,197 117,054 128,117 120,050 83,531 172,301 183,485 197,787 161,928 224,040 256,718 328,319 205,512 196,332 222,717 188,907 176,191 125,073 135,860 97,397 109,138
Depreciation 23,354 23,260 23,627 22,551 22,680 22,861 23,442 21,957 22,503 23,207 22,018 21,938 23,910 22,008 19,806 19,816 18,489 19,326 17,626 17,231 16,651
Stock-based compensation 15,758 12,446 12,787 13,564 18,885 10,808 12,298 12,228 12,894 10,994 11,418 10,999 12,232 11,878 11,661 10,907 10,460 9,075 10,713 8,635 9,474
Provision for excess and obsolete inventory 6,177 5,289 11,728 5,731 5,610 12,523 12,234 5,105 1,590 3,700 8,150 1,340 2,285 4,418 3,479 5,580 4,057 6,396 3,049 3,402 2,397
Amortization 4,766 4,685 4,503 4,654 4,926 4,900 4,917 4,862 5,233 6,786 8,283 9,521 9,822 10,047 10,343 12,843 13,391 12,972 11,873 12,034 12,942
Deferred taxes (9,669) (13,616) (10,455) (5,937) (7,634) (10,320) (4,776) (34,885) 11,288 (6,573) (9,932) 257 (1,057) (11,141) 2,616 (5,338) (1,825) (6,479) (3,492) (691) 1,206
(Gains) losses on investments 10,466 (11,756) 1,586 (2,507) (2,238) (1,451) 2,463 6,972 2,001 (1,660) (100) (2,159) (2,491) (4,383) (3,046) (5,126) 4,657 (1,875) (417) (913) (2,828)
Gains on sale of asset (3,410)
Contingent consideration fair value adjustment (7,227) (15,304) (27,206) 29,259 (10,020) (2,797) (7,759) (11,671) 2,970
Loss on convertible debt conversion 3,431 20,153 1,175 4,069
Retirement plans actuarial (gains) losses 2,703 (25,584) (1,590) (627) 7,695 2,688 (99) 7,728 448
Investment impairment 15,000
Other 787 (942) 79 (200) 108 1,613 218 345 177 28 44 (1) 200 807 227 20 503 156 181 210 219
Accounts receivable (8,055) 40,786 32,884 (39,897) 37,204 46,380 150,632 (146,592) 208 45,521 269,399 (285,186) (87,512) 92,564 109,025 (204,261) (126,779) (3,651) 12,689 (37,772) (41,706)
Inventories (6,932) (1,068) 20,240 9,852 (23,697) (11,992) (22,135) (37,202) (9,480) (15,448) 2,035 55,778 (35,870) (25,436) 20,726 (19,546) 15,818 (13,265) (11,696) 470 (2,917)
Prepayments and other assets 11,089 20,881 (34,398) (14,204) (15,380) (46,382) 420 (20,446) (74,305) (37,282) (21,148) (31,285) (86,131) (23,667) 8,728 (9,859) (39,620) (7,666) 949 1,581 (18,648)
Accounts payable and other liabilities (105,548) 42,783 28,513 58,694 (83,208) 11,175 (28,071) 80,771 (124,382) 64,435 (21,726) 97,361 (10,571) (8,390) (32,021) 148,901 (35,323) 28,472 35,231 38,899 (53,323)
Deferred revenue and customer advances (1,444) (7,693) (14,579) (2,233) (32,705) (337) (20,059) 7,416 6,747 1,174 (6,490) 7,237 7,952 3,385 7,934 29,568 (913) 11,534 11,953 9,371 6,455
Retirement plans contributions (1,421) (1,794) (1,216) (1,248) (1,234) (1,219) (1,279) (1,289) (1,329) (1,282) (1,384) (814) (1,925) (1,498) (1,383) (1,239) (1,262) (1,311) (1,361) (1,204) (1,210)
Income taxes 3,754 15,762 (29,069) (26,102) 12,488 1,536 (42,185) 18,426 (7,611) 11,802 (14,778) (7,569) 4,941 1,109 (13,782) 22,564 15,278 17,640 (16,251) 7,831 (22,804)
Changes in operating assets and liabilities (108,557) 109,657 2,375 (15,138) (106,532) (839) 37,323 (98,916) (210,152) 68,920 205,908 (164,478) (209,116) 38,067 99,227 (33,872) (172,801) 31,753 31,514 19,176 (134,153)
Adjustments to reconcile net income from operations to net cash provided by operating activities (56,918) 131,726 46,230 22,718 (64,195) 11,101 88,119 (82,332) (154,466) 107,243 265,942 (122,035) (167,373) 64,092 119,795 33,990 (133,089) 91,255 63,288 47,861 (91,122)
Net cash provided by operating activities 7,279 248,780 174,347 142,768 19,336 183,402 271,604 115,455 7,462 331,283 522,660 206,284 38,139 260,424 342,512 222,897 43,102 216,328 199,148 145,258 18,016
Purchases of property, plant and equipment (44,023) (44,336) (34,604) (39,258) (41,444) (34,577) (38,929) (45,744) (43,999) (29,310) (29,205) (34,707) (39,250) (38,105) (62,858) (47,314) (36,700) (38,594) (37,092) (33,245) (25,711)
Purchases of marketable securities (16,042) (24,120) (38,768) (29,742) (69,276) (20,234) (19,294) (81,904) (165,977) (152,311) (111,384) (186,482) (211,604) (411,768) (188,880) (112,429) (187,119) (57,162) (121,358) (108,997) (375,184)
Issuance of convertible loan (5,000)
Proceeds from maturities of marketable securities 14,438 13,595 49,450 14,529 7,468 40,849 42,440 42,970 96,682 88,871 111,064 265,985 194,228 170,271 126,423 84,527 98,457 218,455 160,279 91,992 141,201
Proceeds from sales of marketable securities 20,734 24,438 1,386 27,648 7,929 8,858 115,558 113,061 30,581 57,029 93,325 54,819 61,293 2,395 5,950 11,656 15,005 45,312 17,820 37,014 5,440
Proceeds from sale of asset 3,410
Purchase of investment and acquisition of business (12,000) 149 (57,772) (15,000) (6,970)
Proceeds from insurance 873 460 546 2,639 273
Net cash (used for) provided by investing activities (24,020) (30,423) (27,536) (26,823) (94,863) (1,694) 99,775 28,383 (82,713) (35,721) 63,800 87,615 4,667 (277,207) (119,365) (63,014) (110,208) 110,239 22,288 (28,236) (260,951)
Repurchase of common stock (22,117) (50,749) (118,647) (134,537) (93,308) (2,082) (217,201) (331,334) (201,465) (193,820) (209,596) (151,396) (45,188) (9,426) (79,039) (131,218) (121,560) (90,754) (156,468)
Dividend payments (18,370) (16,797) (16,897) (17,019) (17,165) (17,133) (17,136) (17,547) (17,895) (16,266) (16,440) (16,604) (16,667) (16,612) (16,604) (16,580) (16,686) (15,036) (15,250) (15,392) (15,627)
Payments of convertible debt principal (23,529) (9,277) (2,303) (15,155) (14,754) (9,713) (21,598) (20,694) (40,993) (235,169) (15,553) (51,275)
Payments related to net settlement of employee stock compensation awards (13,115) (202) (278) (438) (19,870) (183) (207) (1,732) (31,048) (258) (251) (1,119) (30,675) (279) (216) (449) (22,070) (191) (104) (128) (14,318)
Issuance of common stock under stock purchase and stock option plans 16,934 175 17,485 602 15,997 12,197 61 16,475 96 9 15,437 17,144 1,999 13,771 5 12,752 32 14,191 821 14,268
Payments of contingent consideration (8,852) (27,615)
Net cash used for financing activities (36,668) (91,102) (127,614) (153,695) (129,501) (34,152) (232,060) (372,150) (254,627) (251,241) (461,447) (169,235) (126,661) (14,892) (3,049) (26,450) (113,895) (146,413) (122,723) (105,453) (199,760)
Effects of exchange rate changes on cash and cash equivalents 3,241 (6,645) 4,556 1,750 (537) (3,529) (596) 5,732 2,282 (1,576) (1,372) 883 616 (349) (1,496) 571 (169) 119 (190) (329)
Increase (decrease) in cash and cash equivalents (50,168) 120,610 23,753 (36,000) (205,565) 144,027 138,723 (222,580) (327,596) 42,745 125,013 123,292 (82,972) (31,059) 219,749 131,937 (180,430) 179,985 98,832 11,379 (443,024)

Based on: 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-10-01), 10-Q (reporting date: 2023-07-02), 10-Q (reporting date: 2023-04-02), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-10-02), 10-Q (reporting date: 2022-07-03), 10-Q (reporting date: 2022-04-03), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-10-03), 10-Q (reporting date: 2021-07-04), 10-Q (reporting date: 2021-04-04), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-27), 10-Q (reporting date: 2020-06-28), 10-Q (reporting date: 2020-03-29), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-29), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).

Cash flow statement item Description The company
Net cash provided by operating activities Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Teradyne Inc. net cash provided by operating activities increased from Q3 2023 to Q4 2023 but then decreased significantly from Q4 2023 to Q1 2024.
Net cash (used for) provided by investing activities Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. Teradyne Inc. net cash (used for) provided by investing activities decreased from Q3 2023 to Q4 2023 but then increased from Q4 2023 to Q1 2024 exceeding Q3 2023 level.
Net cash used for financing activities Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. Teradyne Inc. net cash used for financing activities increased from Q3 2023 to Q4 2023 and from Q4 2023 to Q1 2024.